Catalyst Wire Dossier Catalyst Wire Dossier

Pegilodecakin

pegilodecakin · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Pegilodecakin, covering 2020-09-11 to 2026-07-13. Get the full timeline:

Most recent: Clinical Trial Results: A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants [Phase 1]

See pricing